A detailed history of Hillsdale Investment Management Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 28,092 shares of BVS stock, worth $284,852. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,092
Previous 31,192 9.94%
Holding current value
$284,852
Previous $372,000 20.97%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$10.5 - $13.71 $32,550 - $42,501
-3,100 Reduced 9.94%
28,092 $294,000
Q3 2024

Nov 12, 2024

SELL
$5.73 - $11.95 $48,418 - $100,977
-8,450 Reduced 21.32%
31,192 $372,000
Q2 2024

Aug 13, 2024

BUY
$3.96 - $6.93 $19,404 - $33,957
4,900 Added 14.1%
39,642 $227,000
Q1 2024

May 10, 2024

BUY
$4.33 - $5.75 $31,176 - $41,400
7,200 Added 26.14%
34,742 $180,000
Q4 2023

Feb 09, 2024

BUY
$2.89 - $5.34 $79,596 - $147,074
27,542 New
27,542 $145,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $625M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.